Hong Kong Insurance Stock News

SEHK:1876
SEHK:1876Beverage

Budweiser Brewing Company APAC (SEHK:1876) Q4 Loss Tests Premiumization Margin Narrative

Budweiser Brewing Company APAC (SEHK:1876) closed out FY 2025 with Q4 revenue of US$1,073 million and a basic EPS loss of US$0.01, while trailing twelve month EPS was US$0.04 on revenue of US$5.8 billion. Over recent quarters the company reported revenue of US$1,461 million in Q1 2025, US$1,675 million in Q2, US$1,555 million in Q3 and US$1,073 million in Q4, with quarterly EPS ranging from US$0.02 in Q1 to a small loss in Q4. This presents a mixed picture on profitability as margins came...
SEHK:799
SEHK:799Entertainment

Discover 3 Asian Penny Stocks With Market Caps Over US$900M

As global markets navigate a mixed landscape marked by volatility and shifts in investor sentiment, Asia's stock markets continue to capture attention with their unique opportunities. Penny stocks, though often viewed as speculative, can offer intriguing possibilities for growth, particularly when they are supported by strong financial health and solid fundamentals. In this article, we explore three Asian penny stocks that stand out for their potential to deliver impressive returns while...
SEHK:1286
SEHK:1286Machinery

Undiscovered Gems in Asia to Explore This February 2026

As global markets navigate a mix of economic signals, with small-cap and value-oriented stocks gaining traction amidst concerns over artificial intelligence investments, Asia's market landscape presents unique opportunities for investors seeking potential growth. In this dynamic environment, identifying promising stocks often involves looking for companies that can capitalize on regional trends and demonstrate resilience in the face of broader market volatility.
SEHK:6855
SEHK:6855Biotechs

Ascentage China IND Clearance Puts BTK Degrader On Global Cancer Track

Ascentage Pharma Group International (SEHK:6855) received investigational new drug clearance in China for APG-3288, its next generation BTK targeted protein degrader. The Chinese clearance follows earlier U.S. FDA approval for clinical testing, aligning the program across two major drug development markets. APG-3288 is being developed for treatment resistant blood cancers, with a focus on hematologic malignancies that do not respond to existing BTK therapies. For investors tracking oncology...
SEHK:2172
SEHK:2172Medical Equipment

3 Asian Stocks Estimated Up To 29.3% Below Intrinsic Value

As global markets experience volatility influenced by concerns over artificial intelligence disruptions and geopolitical tensions, investors are increasingly turning their attention to value-oriented segments that have lagged behind the high-growth sectors. In Asia, this shift in focus has highlighted opportunities in undervalued stocks, which may present potential for growth as they trade below their intrinsic values. Identifying such stocks requires careful analysis of market conditions and...
SEHK:1928
SEHK:1928Hospitality

Sands China’s Lunar New Year Outreach And What It Means For Investors

Sands China (SEHK:1928) supported local NGOs through its Sands Cares Spring Celebrations during Lunar New Year. The company assembled and distributed festive gift packs in partnership with a local Macao NGO. The initiative focused on social welfare and inclusivity within the Macao community. Sands China, listed in Hong Kong under SEHK:1928, operates integrated resorts in Macao and relies heavily on the region's tourism and entertainment activity. For investors, the latest Sands Cares Spring...
SEHK:268
SEHK:268Software

Asian Growth Leaders With Strong Insider Ownership

As global markets navigate a landscape marked by technological disruptions and geopolitical tensions, Asian equities have been capturing investor attention with their unique growth potential. In this environment, companies in Asia that exhibit high insider ownership are particularly noteworthy, as such ownership can often signal confidence in the company's long-term prospects and align management's interests with those of shareholders.